A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Researchers have found that a small vaccine, currently in its early trial phase, can enhance immune system response to fight ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...